SETD7 and hepatocellular carcinoma: KMT7 (also known as SETD7) was shown to be overexpressed in HCC tumour tissues compared to adjacent non-tumoural liver tissues, and it was shown to be positively correlated with tumour size and poor tumour differentiation leading to poor prognosis in HCC patients [66].